Last reviewed · How we verify
Lactoferrin
At a glance
| Generic name | Lactoferrin |
|---|---|
| Also known as | Pravotin sachets, Bovine Lactoferrin, Standard of care treatment regimens, Pravotin, MamyVital |
| Sponsor | Cairo University |
| Modality | Small molecule |
| Therapeutic area | Other |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- The LISA (Lactoferrin InStead of Antibiotics/Antifungals) Feasibility Study (NA)
- Role of Enteral Lactoferrin as an Adjuvant for Prevention of Sepsis Among Preterm Neonates (PHASE1)
- Para-Probiotic Oral Care in Periodontal Patients With Type 2 Diabetes (NA)
- Lactoferrin-Based Oral Care for Periodontal Health in Pregnancy (NA)
- Feasibility or Oral Lactoferrin to Prevent Iron Deficiency Anemia in Obese Pregnancy (NA)
- Antibacterial Mouthwash for Pharyngeal Gonorrhea Prevention (PHASE2)
- Absorption of Iron From Stabilized Lactoferrin: A Study in Women With Iron Deficiency (NA)
- Role of Lactoferrin in Prevention of Ventilator Associated Pneumonia in Neonates. (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Lactoferrin CI brief — competitive landscape report
- Lactoferrin updates RSS · CI watch RSS
- Cairo University portfolio CI